nodes	percent_of_prediction	percent_of_DWPC	metapath
Aclidinium—BCHE—kidney cancer	0.816	1	CbGaD
Aclidinium—Dysphonia—Pazopanib—kidney cancer	0.0038	0.0223	CcSEcCtD
Aclidinium—CHRM3—ureter—kidney cancer	0.00361	0.778	CbGeAlD
Aclidinium—Diabetes mellitus—Temsirolimus—kidney cancer	0.00277	0.0162	CcSEcCtD
Aclidinium—Dysphonia—Sorafenib—kidney cancer	0.0026	0.0153	CcSEcCtD
Aclidinium—Cardiac failure—Pazopanib—kidney cancer	0.00232	0.0136	CcSEcCtD
Aclidinium—Diabetes mellitus—Everolimus—kidney cancer	0.00206	0.0121	CcSEcCtD
Aclidinium—Nasopharyngitis—Pazopanib—kidney cancer	0.00203	0.0119	CcSEcCtD
Aclidinium—Infestation—Temsirolimus—kidney cancer	0.00185	0.0109	CcSEcCtD
Aclidinium—Infestation NOS—Temsirolimus—kidney cancer	0.00185	0.0109	CcSEcCtD
Aclidinium—Cardiac failure—Everolimus—kidney cancer	0.00183	0.0108	CcSEcCtD
Aclidinium—Infestation NOS—Pazopanib—kidney cancer	0.00175	0.0102	CcSEcCtD
Aclidinium—Infestation—Pazopanib—kidney cancer	0.00175	0.0102	CcSEcCtD
Aclidinium—Sinusitis—Temsirolimus—kidney cancer	0.00174	0.0102	CcSEcCtD
Aclidinium—Urinary retention—Everolimus—kidney cancer	0.0017	0.00998	CcSEcCtD
Aclidinium—Dysphonia—Paclitaxel—kidney cancer	0.00168	0.00986	CcSEcCtD
Aclidinium—Rhinitis—Temsirolimus—kidney cancer	0.00167	0.00979	CcSEcCtD
Aclidinium—Urinary tract disorder—Temsirolimus—kidney cancer	0.00164	0.00964	CcSEcCtD
Aclidinium—Urethral disorder—Temsirolimus—kidney cancer	0.00163	0.00957	CcSEcCtD
Aclidinium—Nasopharyngitis—Everolimus—kidney cancer	0.0016	0.00939	CcSEcCtD
Aclidinium—Cardiac failure—Sorafenib—kidney cancer	0.00159	0.00934	CcSEcCtD
Aclidinium—Eye disorder—Temsirolimus—kidney cancer	0.00156	0.00912	CcSEcCtD
Aclidinium—Urinary tract disorder—Pazopanib—kidney cancer	0.00155	0.00908	CcSEcCtD
Aclidinium—Urethral disorder—Pazopanib—kidney cancer	0.00154	0.00901	CcSEcCtD
Aclidinium—Cardiac failure—Sunitinib—kidney cancer	0.00153	0.00898	CcSEcCtD
Aclidinium—Mediastinal disorder—Temsirolimus—kidney cancer	0.0015	0.0088	CcSEcCtD
Aclidinium—Eye disorder—Pazopanib—kidney cancer	0.00147	0.00859	CcSEcCtD
Aclidinium—Mediastinal disorder—Pazopanib—kidney cancer	0.00141	0.00829	CcSEcCtD
Aclidinium—Nasopharyngitis—Sorafenib—kidney cancer	0.00139	0.00815	CcSEcCtD
Aclidinium—Dysphonia—Capecitabine—kidney cancer	0.00138	0.00809	CcSEcCtD
Aclidinium—Infestation NOS—Everolimus—kidney cancer	0.00138	0.00809	CcSEcCtD
Aclidinium—Infestation—Everolimus—kidney cancer	0.00138	0.00809	CcSEcCtD
Aclidinium—Nasopharyngitis—Sunitinib—kidney cancer	0.00134	0.00784	CcSEcCtD
Aclidinium—Infestation NOS—Erlotinib—kidney cancer	0.00133	0.0078	CcSEcCtD
Aclidinium—Infestation—Erlotinib—kidney cancer	0.00133	0.0078	CcSEcCtD
Aclidinium—Sinusitis—Everolimus—kidney cancer	0.00129	0.00759	CcSEcCtD
Aclidinium—Vision blurred—Pazopanib—kidney cancer	0.00129	0.00754	CcSEcCtD
Aclidinium—Cough—Temsirolimus—kidney cancer	0.00126	0.00742	CcSEcCtD
Aclidinium—Rhinitis—Everolimus—kidney cancer	0.00124	0.00728	CcSEcCtD
Aclidinium—Cardiac failure—Gemcitabine—kidney cancer	0.00123	0.00721	CcSEcCtD
Aclidinium—Urinary tract disorder—Everolimus—kidney cancer	0.00122	0.00717	CcSEcCtD
Aclidinium—Urethral disorder—Everolimus—kidney cancer	0.00121	0.00712	CcSEcCtD
Aclidinium—Urinary retention—Vincristine—kidney cancer	0.0012	0.00705	CcSEcCtD
Aclidinium—Infestation—Sorafenib—kidney cancer	0.0012	0.00702	CcSEcCtD
Aclidinium—Infestation NOS—Sorafenib—kidney cancer	0.0012	0.00702	CcSEcCtD
Aclidinium—Cough—Pazopanib—kidney cancer	0.00119	0.00699	CcSEcCtD
Aclidinium—Urinary tract disorder—Erlotinib—kidney cancer	0.00118	0.00692	CcSEcCtD
Aclidinium—Infection—Temsirolimus—kidney cancer	0.00117	0.00689	CcSEcCtD
Aclidinium—Urethral disorder—Erlotinib—kidney cancer	0.00117	0.00687	CcSEcCtD
Aclidinium—Nervous system disorder—Temsirolimus—kidney cancer	0.00116	0.0068	CcSEcCtD
Aclidinium—Eye disorder—Everolimus—kidney cancer	0.00116	0.00679	CcSEcCtD
Aclidinium—Infestation—Sunitinib—kidney cancer	0.00115	0.00676	CcSEcCtD
Aclidinium—Infestation NOS—Sunitinib—kidney cancer	0.00115	0.00676	CcSEcCtD
Aclidinium—Dry mouth—Pazopanib—kidney cancer	0.00114	0.00667	CcSEcCtD
Aclidinium—Eye disorder—Erlotinib—kidney cancer	0.00112	0.00655	CcSEcCtD
Aclidinium—Mediastinal disorder—Everolimus—kidney cancer	0.00112	0.00654	CcSEcCtD
Aclidinium—Infection—Pazopanib—kidney cancer	0.00111	0.00649	CcSEcCtD
Aclidinium—Nervous system disorder—Pazopanib—kidney cancer	0.00109	0.00641	CcSEcCtD
Aclidinium—Mediastinal disorder—Erlotinib—kidney cancer	0.00108	0.00631	CcSEcCtD
Aclidinium—Urinary tract disorder—Sorafenib—kidney cancer	0.00106	0.00622	CcSEcCtD
Aclidinium—Urethral disorder—Sorafenib—kidney cancer	0.00105	0.00618	CcSEcCtD
Aclidinium—Cardiac failure—Paclitaxel—kidney cancer	0.00103	0.00603	CcSEcCtD
Aclidinium—Urinary tract disorder—Sunitinib—kidney cancer	0.00102	0.00599	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Temsirolimus—kidney cancer	0.00102	0.00599	CcSEcCtD
Aclidinium—Vision blurred—Everolimus—kidney cancer	0.00102	0.00596	CcSEcCtD
Aclidinium—Urethral disorder—Sunitinib—kidney cancer	0.00101	0.00595	CcSEcCtD
Aclidinium—Mediastinal disorder—Sorafenib—kidney cancer	0.000969	0.00568	CcSEcCtD
Aclidinium—Eye disorder—Sunitinib—kidney cancer	0.000966	0.00567	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Pazopanib—kidney cancer	0.000962	0.00564	CcSEcCtD
Aclidinium—Diabetes mellitus—Capecitabine—kidney cancer	0.000947	0.00556	CcSEcCtD
Aclidinium—Cough—Everolimus—kidney cancer	0.00094	0.00552	CcSEcCtD
Aclidinium—Mediastinal disorder—Sunitinib—kidney cancer	0.000932	0.00547	CcSEcCtD
Aclidinium—Cough—Erlotinib—kidney cancer	0.000907	0.00532	CcSEcCtD
Aclidinium—Nasopharyngitis—Paclitaxel—kidney cancer	0.000898	0.00527	CcSEcCtD
Aclidinium—Dry mouth—Everolimus—kidney cancer	0.000897	0.00526	CcSEcCtD
Aclidinium—Dysphonia—Doxorubicin—kidney cancer	0.000889	0.00522	CcSEcCtD
Aclidinium—Infection—Everolimus—kidney cancer	0.000874	0.00512	CcSEcCtD
Aclidinium—Urinary tract disorder—Vincristine—kidney cancer	0.000864	0.00507	CcSEcCtD
Aclidinium—Nervous system disorder—Everolimus—kidney cancer	0.000863	0.00506	CcSEcCtD
Aclidinium—Tachycardia—Everolimus—kidney cancer	0.000858	0.00503	CcSEcCtD
Aclidinium—Urethral disorder—Vincristine—kidney cancer	0.000857	0.00503	CcSEcCtD
Aclidinium—Cardiac failure—Capecitabine—kidney cancer	0.000844	0.00495	CcSEcCtD
Aclidinium—Infection—Erlotinib—kidney cancer	0.000843	0.00494	CcSEcCtD
Aclidinium—Nervous system disorder—Erlotinib—kidney cancer	0.000832	0.00488	CcSEcCtD
Aclidinium—Rhinitis—Gemcitabine—kidney cancer	0.000832	0.00488	CcSEcCtD
Aclidinium—Osteoarthritis—Capecitabine—kidney cancer	0.000824	0.00483	CcSEcCtD
Aclidinium—Urinary tract disorder—Gemcitabine—kidney cancer	0.000819	0.00481	CcSEcCtD
Aclidinium—Cough—Sorafenib—kidney cancer	0.000816	0.00479	CcSEcCtD
Aclidinium—Urethral disorder—Gemcitabine—kidney cancer	0.000813	0.00477	CcSEcCtD
Aclidinium—Diarrhoea—Temsirolimus—kidney cancer	0.000809	0.00475	CcSEcCtD
Aclidinium—Mediastinal disorder—Vincristine—kidney cancer	0.000788	0.00462	CcSEcCtD
Aclidinium—Cough—Sunitinib—kidney cancer	0.000786	0.00461	CcSEcCtD
Aclidinium—Urinary retention—Capecitabine—kidney cancer	0.000784	0.0046	CcSEcCtD
Aclidinium—Dry mouth—Sorafenib—kidney cancer	0.000779	0.00457	CcSEcCtD
Aclidinium—Infestation NOS—Paclitaxel—kidney cancer	0.000774	0.00454	CcSEcCtD
Aclidinium—Infestation—Paclitaxel—kidney cancer	0.000774	0.00454	CcSEcCtD
Aclidinium—Diarrhoea—Pazopanib—kidney cancer	0.000762	0.00447	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Everolimus—kidney cancer	0.000759	0.00445	CcSEcCtD
Aclidinium—Infection—Sorafenib—kidney cancer	0.000758	0.00445	CcSEcCtD
Aclidinium—Vomiting—Temsirolimus—kidney cancer	0.000752	0.00441	CcSEcCtD
Aclidinium—Dry mouth—Sunitinib—kidney cancer	0.000749	0.0044	CcSEcCtD
Aclidinium—Nervous system disorder—Sorafenib—kidney cancer	0.000749	0.00439	CcSEcCtD
Aclidinium—Mediastinal disorder—Gemcitabine—kidney cancer	0.000748	0.00439	CcSEcCtD
Aclidinium—Headache—Temsirolimus—kidney cancer	0.000741	0.00434	CcSEcCtD
Aclidinium—Nasopharyngitis—Capecitabine—kidney cancer	0.000737	0.00432	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Erlotinib—kidney cancer	0.000733	0.0043	CcSEcCtD
Aclidinium—Infection—Sunitinib—kidney cancer	0.00073	0.00428	CcSEcCtD
Aclidinium—Sinusitis—Paclitaxel—kidney cancer	0.000726	0.00426	CcSEcCtD
Aclidinium—Nervous system disorder—Sunitinib—kidney cancer	0.00072	0.00423	CcSEcCtD
Aclidinium—Vomiting—Pazopanib—kidney cancer	0.000708	0.00415	CcSEcCtD
Aclidinium—Headache—Pazopanib—kidney cancer	0.000698	0.00409	CcSEcCtD
Aclidinium—Rhinitis—Paclitaxel—kidney cancer	0.000696	0.00408	CcSEcCtD
Aclidinium—Infection—Dactinomycin—kidney cancer	0.000691	0.00405	CcSEcCtD
Aclidinium—Urinary tract disorder—Paclitaxel—kidney cancer	0.000686	0.00402	CcSEcCtD
Aclidinium—Urethral disorder—Paclitaxel—kidney cancer	0.000681	0.00399	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000659	0.00387	CcSEcCtD
Aclidinium—Eye disorder—Paclitaxel—kidney cancer	0.000649	0.00381	CcSEcCtD
Aclidinium—Infestation—Capecitabine—kidney cancer	0.000635	0.00372	CcSEcCtD
Aclidinium—Infestation NOS—Capecitabine—kidney cancer	0.000635	0.00372	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000634	0.00372	CcSEcCtD
Aclidinium—Cough—Gemcitabine—kidney cancer	0.00063	0.0037	CcSEcCtD
Aclidinium—Mediastinal disorder—Paclitaxel—kidney cancer	0.000626	0.00367	CcSEcCtD
Aclidinium—Infection—Vincristine—kidney cancer	0.000617	0.00362	CcSEcCtD
Aclidinium—Diabetes mellitus—Doxorubicin—kidney cancer	0.000611	0.00358	CcSEcCtD
Aclidinium—Nervous system disorder—Vincristine—kidney cancer	0.000609	0.00357	CcSEcCtD
Aclidinium—Diarrhoea—Vinblastine—kidney cancer	0.000604	0.00354	CcSEcCtD
Aclidinium—Diarrhoea—Everolimus—kidney cancer	0.000602	0.00353	CcSEcCtD
Aclidinium—Infection—Gemcitabine—kidney cancer	0.000586	0.00343	CcSEcCtD
Aclidinium—Diarrhoea—Erlotinib—kidney cancer	0.000581	0.00341	CcSEcCtD
Aclidinium—Nervous system disorder—Gemcitabine—kidney cancer	0.000578	0.00339	CcSEcCtD
Aclidinium—Rhinitis—Capecitabine—kidney cancer	0.000572	0.00335	CcSEcCtD
Aclidinium—Vision blurred—Paclitaxel—kidney cancer	0.00057	0.00334	CcSEcCtD
Aclidinium—Urinary tract disorder—Capecitabine—kidney cancer	0.000563	0.0033	CcSEcCtD
Aclidinium—Vomiting—Vinblastine—kidney cancer	0.000561	0.00329	CcSEcCtD
Aclidinium—Vomiting—Everolimus—kidney cancer	0.000559	0.00328	CcSEcCtD
Aclidinium—Urethral disorder—Capecitabine—kidney cancer	0.000559	0.00328	CcSEcCtD
Aclidinium—Headache—Vinblastine—kidney cancer	0.000553	0.00324	CcSEcCtD
Aclidinium—Headache—Everolimus—kidney cancer	0.000551	0.00323	CcSEcCtD
Aclidinium—Cardiac failure—Doxorubicin—kidney cancer	0.000544	0.00319	CcSEcCtD
Aclidinium—Vomiting—Erlotinib—kidney cancer	0.00054	0.00316	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Vincristine—kidney cancer	0.000536	0.00315	CcSEcCtD
Aclidinium—Eye disorder—Capecitabine—kidney cancer	0.000533	0.00312	CcSEcCtD
Aclidinium—Headache—Erlotinib—kidney cancer	0.000532	0.00312	CcSEcCtD
Aclidinium—Osteoarthritis—Doxorubicin—kidney cancer	0.000531	0.00312	CcSEcCtD
Aclidinium—Cough—Paclitaxel—kidney cancer	0.000528	0.0031	CcSEcCtD
Aclidinium—Diarrhoea—Sorafenib—kidney cancer	0.000522	0.00306	CcSEcCtD
Aclidinium—Mediastinal disorder—Capecitabine—kidney cancer	0.000514	0.00301	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000509	0.00298	CcSEcCtD
Aclidinium—Dry mouth—Paclitaxel—kidney cancer	0.000504	0.00295	CcSEcCtD
Aclidinium—Diarrhoea—Sunitinib—kidney cancer	0.000503	0.00295	CcSEcCtD
Aclidinium—Infection—Paclitaxel—kidney cancer	0.00049	0.00288	CcSEcCtD
Aclidinium—Vomiting—Sorafenib—kidney cancer	0.000485	0.00285	CcSEcCtD
Aclidinium—Nervous system disorder—Paclitaxel—kidney cancer	0.000484	0.00284	CcSEcCtD
Aclidinium—Tachycardia—Paclitaxel—kidney cancer	0.000482	0.00283	CcSEcCtD
Aclidinium—Headache—Sorafenib—kidney cancer	0.000478	0.00281	CcSEcCtD
Aclidinium—Diarrhoea—Dactinomycin—kidney cancer	0.000476	0.00279	CcSEcCtD
Aclidinium—Nasopharyngitis—Doxorubicin—kidney cancer	0.000475	0.00279	CcSEcCtD
Aclidinium—Vision blurred—Capecitabine—kidney cancer	0.000468	0.00274	CcSEcCtD
Aclidinium—Vomiting—Sunitinib—kidney cancer	0.000467	0.00274	CcSEcCtD
Aclidinium—Headache—Sunitinib—kidney cancer	0.00046	0.0027	CcSEcCtD
Aclidinium—Vomiting—Dactinomycin—kidney cancer	0.000442	0.00259	CcSEcCtD
Aclidinium—Cough—Capecitabine—kidney cancer	0.000433	0.00254	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000426	0.0025	CcSEcCtD
Aclidinium—Diarrhoea—Vincristine—kidney cancer	0.000425	0.00249	CcSEcCtD
Aclidinium—Dry mouth—Capecitabine—kidney cancer	0.000413	0.00242	CcSEcCtD
Aclidinium—Infestation—Doxorubicin—kidney cancer	0.000409	0.0024	CcSEcCtD
Aclidinium—Infestation NOS—Doxorubicin—kidney cancer	0.000409	0.0024	CcSEcCtD
Aclidinium—Diarrhoea—Gemcitabine—kidney cancer	0.000403	0.00237	CcSEcCtD
Aclidinium—Infection—Capecitabine—kidney cancer	0.000402	0.00236	CcSEcCtD
Aclidinium—Nervous system disorder—Capecitabine—kidney cancer	0.000397	0.00233	CcSEcCtD
Aclidinium—Tachycardia—Capecitabine—kidney cancer	0.000395	0.00232	CcSEcCtD
Aclidinium—Vomiting—Vincristine—kidney cancer	0.000395	0.00232	CcSEcCtD
Aclidinium—Headache—Vincristine—kidney cancer	0.000389	0.00228	CcSEcCtD
Aclidinium—Sinusitis—Doxorubicin—kidney cancer	0.000384	0.00225	CcSEcCtD
Aclidinium—Vomiting—Gemcitabine—kidney cancer	0.000375	0.0022	CcSEcCtD
Aclidinium—Headache—Gemcitabine—kidney cancer	0.000369	0.00217	CcSEcCtD
Aclidinium—Rhinitis—Doxorubicin—kidney cancer	0.000368	0.00216	CcSEcCtD
Aclidinium—Urinary tract disorder—Doxorubicin—kidney cancer	0.000363	0.00213	CcSEcCtD
Aclidinium—Urethral disorder—Doxorubicin—kidney cancer	0.00036	0.00211	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Capecitabine—kidney cancer	0.00035	0.00205	CcSEcCtD
Aclidinium—Eye disorder—Doxorubicin—kidney cancer	0.000343	0.00201	CcSEcCtD
Aclidinium—Diarrhoea—Paclitaxel—kidney cancer	0.000338	0.00198	CcSEcCtD
Aclidinium—Mediastinal disorder—Doxorubicin—kidney cancer	0.000331	0.00194	CcSEcCtD
Aclidinium—Vomiting—Paclitaxel—kidney cancer	0.000314	0.00184	CcSEcCtD
Aclidinium—Headache—Paclitaxel—kidney cancer	0.000309	0.00181	CcSEcCtD
Aclidinium—Vision blurred—Doxorubicin—kidney cancer	0.000301	0.00177	CcSEcCtD
Aclidinium—CHRM3—renal system—kidney cancer	0.000287	0.0618	CbGeAlD
Aclidinium—Cough—Doxorubicin—kidney cancer	0.000279	0.00164	CcSEcCtD
Aclidinium—CHRM3—kidney—kidney cancer	0.000277	0.0598	CbGeAlD
Aclidinium—Diarrhoea—Capecitabine—kidney cancer	0.000277	0.00163	CcSEcCtD
Aclidinium—Dry mouth—Doxorubicin—kidney cancer	0.000266	0.00156	CcSEcCtD
Aclidinium—Infection—Doxorubicin—kidney cancer	0.000259	0.00152	CcSEcCtD
Aclidinium—BCHE—nephron tubule—kidney cancer	0.000258	0.0555	CbGeAlD
Aclidinium—Vomiting—Capecitabine—kidney cancer	0.000258	0.00151	CcSEcCtD
Aclidinium—Nervous system disorder—Doxorubicin—kidney cancer	0.000256	0.0015	CcSEcCtD
Aclidinium—Tachycardia—Doxorubicin—kidney cancer	0.000255	0.00149	CcSEcCtD
Aclidinium—Headache—Capecitabine—kidney cancer	0.000254	0.00149	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000225	0.00132	CcSEcCtD
Aclidinium—BCHE—cardiac atrium—kidney cancer	0.00021	0.0452	CbGeAlD
Aclidinium—Diarrhoea—Doxorubicin—kidney cancer	0.000179	0.00105	CcSEcCtD
Aclidinium—Vomiting—Doxorubicin—kidney cancer	0.000166	0.000974	CcSEcCtD
Aclidinium—Headache—Doxorubicin—kidney cancer	0.000164	0.000959	CcSEcCtD
Aclidinium—BCHE—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	6.79e-06	0.000726	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—POMC—kidney cancer	6.76e-06	0.000723	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—JUNB—kidney cancer	6.64e-06	0.000711	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—PAK1—kidney cancer	6.64e-06	0.000711	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—GSTT1—kidney cancer	6.47e-06	0.000693	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—ACHE—kidney cancer	6.47e-06	0.000693	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—POMC—kidney cancer	6.47e-06	0.000693	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—GRB7—kidney cancer	6.4e-06	0.000685	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—GRB7—kidney cancer	6.38e-06	0.000683	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—JUNB—kidney cancer	6.36e-06	0.000681	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—PAK1—kidney cancer	6.36e-06	0.000681	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—GRB7—kidney cancer	6.32e-06	0.000677	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—POMC—kidney cancer	6.14e-06	0.000657	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—SCARB1—kidney cancer	6.13e-06	0.000656	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—PTGS1—kidney cancer	6.06e-06	0.000649	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—ITPR2—kidney cancer	5.95e-06	0.000637	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—PSMD7—kidney cancer	5.95e-06	0.000637	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—ITPR2—kidney cancer	5.93e-06	0.000635	CbGpPWpGaD
Aclidinium—BCHE—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.92e-06	0.000634	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—ITPR2—kidney cancer	5.88e-06	0.000629	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—POMC—kidney cancer	5.88e-06	0.000629	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—GSTP1—kidney cancer	5.83e-06	0.000624	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—BCHE—kidney cancer	5.64e-06	0.000604	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—SLC5A5—kidney cancer	5.57e-06	0.000596	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—ABCB1—kidney cancer	5.52e-06	0.000591	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—IGF2—kidney cancer	5.43e-06	0.000581	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CDKN2B—kidney cancer	5.41e-06	0.000579	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CTNNA1—kidney cancer	5.4e-06	0.000578	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CTNNA1—kidney cancer	5.38e-06	0.000576	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—SLC2A1—kidney cancer	5.38e-06	0.000576	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—EIF4EBP1—kidney cancer	5.37e-06	0.000574	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—HSPB1—kidney cancer	5.37e-06	0.000574	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—GSTM1—kidney cancer	5.36e-06	0.000574	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—HSPB1—kidney cancer	5.35e-06	0.000573	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—EIF4EBP1—kidney cancer	5.35e-06	0.000573	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CTNNA1—kidney cancer	5.33e-06	0.00057	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—EIF4EBP1—kidney cancer	5.3e-06	0.000567	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—HSPB1—kidney cancer	5.3e-06	0.000567	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—IGF1R—kidney cancer	5.25e-06	0.000562	CbGpPWpGaD
Aclidinium—BCHE—Metabolism of proteins—CTNNB1—kidney cancer	5.25e-06	0.000562	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—IGF2—kidney cancer	5.2e-06	0.000557	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CDKN2B—kidney cancer	5.18e-06	0.000554	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—CYP1A1—kidney cancer	5.08e-06	0.000544	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—RAF1—kidney cancer	5.06e-06	0.000542	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—IGF1R—kidney cancer	5.03e-06	0.000538	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—IL2—kidney cancer	4.99e-06	0.000535	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—TSC1—kidney cancer	4.99e-06	0.000534	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—PSMD7—kidney cancer	4.99e-06	0.000534	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—ANXA1—kidney cancer	4.99e-06	0.000534	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—ANXA1—kidney cancer	4.97e-06	0.000532	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—PSMD7—kidney cancer	4.97e-06	0.000532	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—TSC1—kidney cancer	4.97e-06	0.000532	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—TSC1—kidney cancer	4.92e-06	0.000527	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—PSMD7—kidney cancer	4.92e-06	0.000527	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—ANXA1—kidney cancer	4.92e-06	0.000527	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—RAF1—kidney cancer	4.84e-06	0.000519	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—FLT1—kidney cancer	4.83e-06	0.000517	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—FLT1—kidney cancer	4.82e-06	0.000516	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—IL2—kidney cancer	4.78e-06	0.000512	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—FLT1—kidney cancer	4.77e-06	0.000511	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—POMC—kidney cancer	4.56e-06	0.000488	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—POMC—kidney cancer	4.54e-06	0.000486	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—IL2—kidney cancer	4.54e-06	0.000486	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—POMC—kidney cancer	4.5e-06	0.000481	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—GSTP1—kidney cancer	4.49e-06	0.00048	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—JUNB—kidney cancer	4.48e-06	0.000479	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—PAK1—kidney cancer	4.48e-06	0.000479	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—JUNB—kidney cancer	4.46e-06	0.000478	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—PAK1—kidney cancer	4.46e-06	0.000478	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—JUNB—kidney cancer	4.42e-06	0.000473	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—PAK1—kidney cancer	4.42e-06	0.000473	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—IL2—kidney cancer	4.34e-06	0.000465	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—HIF1A—kidney cancer	4.32e-06	0.000463	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—TSC2—kidney cancer	4.31e-06	0.000462	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—ABCB1—kidney cancer	4.25e-06	0.000455	CbGpPWpGaD
Aclidinium—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.17e-06	0.000447	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—HIF1A—kidney cancer	4.14e-06	0.000443	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—POMC—kidney cancer	4.14e-06	0.000443	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—KDR—kidney cancer	4.13e-06	0.000443	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—TSC2—kidney cancer	4.13e-06	0.000442	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—POMC—kidney cancer	4.12e-06	0.000441	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—GSTM1—kidney cancer	4.12e-06	0.000441	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—POMC—kidney cancer	4.08e-06	0.000437	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—KDR—kidney cancer	3.96e-06	0.000424	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—CYP1A1—kidney cancer	3.91e-06	0.000418	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—APC—kidney cancer	3.81e-06	0.000408	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—KIT—kidney cancer	3.81e-06	0.000408	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—POMC—kidney cancer	3.79e-06	0.000406	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—IGF2—kidney cancer	3.66e-06	0.000392	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—IGF2—kidney cancer	3.65e-06	0.000391	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—MAPK3—kidney cancer	3.65e-06	0.00039	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—APC—kidney cancer	3.65e-06	0.00039	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—KIT—kidney cancer	3.65e-06	0.00039	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CDKN2B—kidney cancer	3.65e-06	0.00039	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CDKN2B—kidney cancer	3.63e-06	0.000389	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—POMC—kidney cancer	3.62e-06	0.000388	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—IGF2—kidney cancer	3.61e-06	0.000387	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CDKN2B—kidney cancer	3.6e-06	0.000385	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—BRAF—kidney cancer	3.58e-06	0.000383	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—IGF1R—kidney cancer	3.54e-06	0.000379	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—IGF1R—kidney cancer	3.53e-06	0.000378	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—IGF1R—kidney cancer	3.49e-06	0.000374	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—MAPK3—kidney cancer	3.49e-06	0.000374	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—POMC—kidney cancer	3.47e-06	0.000372	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—MAPK1—kidney cancer	3.47e-06	0.000371	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—BRAF—kidney cancer	3.43e-06	0.000367	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—RAF1—kidney cancer	3.41e-06	0.000365	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—RAF1—kidney cancer	3.4e-06	0.000364	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—IL2—kidney cancer	3.37e-06	0.000361	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—RAF1—kidney cancer	3.37e-06	0.00036	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—IL2—kidney cancer	3.36e-06	0.000359	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—IL2—kidney cancer	3.32e-06	0.000356	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—MAPK1—kidney cancer	3.32e-06	0.000356	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—PIK3CA—kidney cancer	3.32e-06	0.000355	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—KRAS—kidney cancer	3.28e-06	0.000351	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—PIK3CA—kidney cancer	3.18e-06	0.00034	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—KRAS—kidney cancer	3.14e-06	0.000336	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—IL2—kidney cancer	3.06e-06	0.000327	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—IL2—kidney cancer	3.05e-06	0.000326	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—PTGS2—kidney cancer	3.02e-06	0.000324	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—IL2—kidney cancer	3.02e-06	0.000323	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—PIK3CA—kidney cancer	3.01e-06	0.000322	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—RAF1—kidney cancer	2.99e-06	0.00032	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—RELA—kidney cancer	2.98e-06	0.000319	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—ERBB2—kidney cancer	2.96e-06	0.000317	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—MTOR—kidney cancer	2.92e-06	0.000312	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—HIF1A—kidney cancer	2.91e-06	0.000312	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—POMC—kidney cancer	2.91e-06	0.000312	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—TSC2—kidney cancer	2.91e-06	0.000311	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—HIF1A—kidney cancer	2.9e-06	0.000311	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—TSC2—kidney cancer	2.9e-06	0.00031	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—PIK3CA—kidney cancer	2.88e-06	0.000309	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—HIF1A—kidney cancer	2.88e-06	0.000308	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—TSC2—kidney cancer	2.87e-06	0.000307	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—RAF1—kidney cancer	2.86e-06	0.000306	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—RELA—kidney cancer	2.85e-06	0.000305	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—ERBB2—kidney cancer	2.83e-06	0.000303	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—MTOR—kidney cancer	2.79e-06	0.000299	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—KDR—kidney cancer	2.79e-06	0.000298	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—KDR—kidney cancer	2.78e-06	0.000297	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—KDR—kidney cancer	2.75e-06	0.000295	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CDKN1B—kidney cancer	2.74e-06	0.000293	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—IL2—kidney cancer	2.68e-06	0.000287	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—PTEN—kidney cancer	2.64e-06	0.000282	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CDKN1B—kidney cancer	2.62e-06	0.000281	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CCND1—kidney cancer	2.61e-06	0.00028	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—JUN—kidney cancer	2.61e-06	0.000279	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CTNNB1—kidney cancer	2.59e-06	0.000277	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—APC—kidney cancer	2.57e-06	0.000275	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—KIT—kidney cancer	2.57e-06	0.000275	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—IL2—kidney cancer	2.57e-06	0.000275	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—APC—kidney cancer	2.56e-06	0.000274	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—KIT—kidney cancer	2.56e-06	0.000274	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—KIT—kidney cancer	2.53e-06	0.000271	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—APC—kidney cancer	2.53e-06	0.000271	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—PTEN—kidney cancer	2.52e-06	0.00027	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CCND1—kidney cancer	2.5e-06	0.000268	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—JUN—kidney cancer	2.5e-06	0.000267	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CTNNB1—kidney cancer	2.48e-06	0.000265	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—MAPK3—kidney cancer	2.46e-06	0.000263	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—MAPK3—kidney cancer	2.45e-06	0.000262	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—POMC—kidney cancer	2.44e-06	0.000262	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—POMC—kidney cancer	2.44e-06	0.000261	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—MAPK3—kidney cancer	2.43e-06	0.00026	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—PTEN—kidney cancer	2.41e-06	0.000258	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—BRAF—kidney cancer	2.41e-06	0.000258	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—POMC—kidney cancer	2.41e-06	0.000258	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—BRAF—kidney cancer	2.41e-06	0.000258	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—BRAF—kidney cancer	2.38e-06	0.000255	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—MAPK1—kidney cancer	2.34e-06	0.00025	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—MAPK1—kidney cancer	2.33e-06	0.00025	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—PTGS2—kidney cancer	2.32e-06	0.000249	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—MAPK1—kidney cancer	2.31e-06	0.000247	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—VEGFA—kidney cancer	2.28e-06	0.000244	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—PIK3CA—kidney cancer	2.24e-06	0.000239	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—PIK3CA—kidney cancer	2.23e-06	0.000239	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—KRAS—kidney cancer	2.21e-06	0.000237	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—PIK3CA—kidney cancer	2.21e-06	0.000236	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—KRAS—kidney cancer	2.2e-06	0.000236	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—KRAS—kidney cancer	2.18e-06	0.000234	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—VEGFA—kidney cancer	2.18e-06	0.000233	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—MAPK3—kidney cancer	2.15e-06	0.000231	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—MYC—kidney cancer	2.1e-06	0.000224	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—MAPK3—kidney cancer	2.06e-06	0.000221	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—MAPK1—kidney cancer	2.05e-06	0.000219	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—PIK3CA—kidney cancer	2.03e-06	0.000217	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—PTEN—kidney cancer	2.03e-06	0.000217	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—PIK3CA—kidney cancer	2.02e-06	0.000217	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—RAF1—kidney cancer	2.02e-06	0.000216	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—RAF1—kidney cancer	2.01e-06	0.000215	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—MYC—kidney cancer	2.01e-06	0.000215	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—RELA—kidney cancer	2.01e-06	0.000215	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—PIK3CA—kidney cancer	2e-06	0.000215	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—RELA—kidney cancer	2e-06	0.000214	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—ERBB2—kidney cancer	1.99e-06	0.000213	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—RAF1—kidney cancer	1.99e-06	0.000213	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—ERBB2—kidney cancer	1.99e-06	0.000213	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—RELA—kidney cancer	1.98e-06	0.000212	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—ERBB2—kidney cancer	1.97e-06	0.000211	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—MTOR—kidney cancer	1.97e-06	0.000211	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—MAPK1—kidney cancer	1.96e-06	0.00021	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—MTOR—kidney cancer	1.96e-06	0.00021	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—MTOR—kidney cancer	1.94e-06	0.000208	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—KRAS—kidney cancer	1.94e-06	0.000207	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—PIK3CA—kidney cancer	1.86e-06	0.000199	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—KRAS—kidney cancer	1.85e-06	0.000198	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CDKN1B—kidney cancer	1.85e-06	0.000198	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CDKN1B—kidney cancer	1.84e-06	0.000197	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CDKN1B—kidney cancer	1.82e-06	0.000195	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—IL2—kidney cancer	1.81e-06	0.000193	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—IL2—kidney cancer	1.8e-06	0.000193	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—IL2—kidney cancer	1.78e-06	0.000191	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—PIK3CA—kidney cancer	1.78e-06	0.00019	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CCND1—kidney cancer	1.76e-06	0.000189	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—JUN—kidney cancer	1.76e-06	0.000188	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CCND1—kidney cancer	1.76e-06	0.000188	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—JUN—kidney cancer	1.75e-06	0.000188	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CTNNB1—kidney cancer	1.74e-06	0.000187	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CCND1—kidney cancer	1.74e-06	0.000186	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CTNNB1—kidney cancer	1.74e-06	0.000186	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—JUN—kidney cancer	1.73e-06	0.000186	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CTNNB1—kidney cancer	1.72e-06	0.000184	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—TP53—kidney cancer	1.72e-06	0.000184	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—PIK3CA—kidney cancer	1.7e-06	0.000182	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—PTEN—kidney cancer	1.7e-06	0.000182	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—PTEN—kidney cancer	1.69e-06	0.000181	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—PTEN—kidney cancer	1.68e-06	0.00018	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—TP53—kidney cancer	1.65e-06	0.000176	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—VEGFA—kidney cancer	1.54e-06	0.000164	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—VEGFA—kidney cancer	1.53e-06	0.000164	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—VEGFA—kidney cancer	1.52e-06	0.000162	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—MAPK3—kidney cancer	1.45e-06	0.000156	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—MAPK3—kidney cancer	1.45e-06	0.000155	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—MAPK3—kidney cancer	1.43e-06	0.000154	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—PIK3CA—kidney cancer	1.43e-06	0.000153	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—MYC—kidney cancer	1.41e-06	0.000151	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—MYC—kidney cancer	1.41e-06	0.000151	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—MYC—kidney cancer	1.39e-06	0.000149	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—MAPK1—kidney cancer	1.38e-06	0.000148	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—MAPK1—kidney cancer	1.38e-06	0.000147	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—MAPK1—kidney cancer	1.36e-06	0.000146	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—KRAS—kidney cancer	1.31e-06	0.00014	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—KRAS—kidney cancer	1.3e-06	0.000139	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—KRAS—kidney cancer	1.29e-06	0.000138	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—PIK3CA—kidney cancer	1.2e-06	0.000128	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—PIK3CA—kidney cancer	1.2e-06	0.000128	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—PIK3CA—kidney cancer	1.18e-06	0.000127	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—TP53—kidney cancer	1.16e-06	0.000124	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—TP53—kidney cancer	1.16e-06	0.000124	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—TP53—kidney cancer	1.15e-06	0.000123	CbGpPWpGaD
